ISSN:
1432-1084
Keywords:
Iotrolan
;
Iopamidol
;
Iohexol
;
Contrast agents
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract The ongoing clinical development of iotrolan 280 mgl/ml for intravascular indications in the United States includes computed tomography, excretory urography, cerebral arteriography, aortography/visceral angiography, and peripheral arteriography. The safety, efficacy and patient tolerance of iotrolan has been assessed in two phase I and ten phase II and III multicenter, randomized, double-blind trials involving over 500 patients and volunteers. Each indication has been studied in two double-blind trials. It is anticipated that once these trials are complete, the data will permit a New Drug Application to be submitted to the US Food and Drug Administration.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF02343270
Permalink